Rapid Response COVID-19 Test - Box of 25 Test - Professional Kits (In Stock Now)
Currently in stock
Rapid Response (NP/OP/Anterior Nares)
Please note this product can not be broken down into individual test kits.
The Rapid Response™ COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset and from individuals without symptoms or other epidemiological reasons to suspect COVID-19 infection, when tested twice over two (or three) days with at least 24 hours (and no more than 36 hours) between tests. This test is authorized for use at the Point of Care i.e., in patient care setting.
Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigens are generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories are required to report all positive results to the appropriate public health authorities.
Product Information
Product Code: COV-19C25
Sample: Nasal / Nasopharyngeal secretions
Format: Cassette
Quantity: 25 Tests/Kit
Time to result: 15 minutes
Storage Condition: 2-30°C/36-86°F
Test Principle: Immunochromatographic Assay
Contents
Individually packed test devices
Extraction Buffer
Extraction tube
Nozzle with filter
Tube stand
Individually packed swabs
Package Insert
The Rapid Response™ antigen test device is the perfect screening tool for organizations that want to try to protect their workplace from the risk of COVID-19 lockdowns.
Used as part of a comprehensive rapid testing program for COVID-19, the BTNX nasal device offers fast, easy-to-use, and reliable screening. Testing all staff 1-2 times/week will help detect the virus early and decrease the likelihood of spreading COVID-19.
Rapid Response® COVID-19 Antigen Rapid Test Device. It is an efficient, accurate, and reliable method of testing that can be used by any health care professional. It is easy to use and delivers results within 15 minutes!
The BTNX Rapid Response™ COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal secretion samples.
The Rapid Response™ antigen test device is the perfect screening tool for organizations that want to protect their workplace from the risk of COVID-19 lockdowns.
Used as part of a comprehensive rapid testing program for COVID-19, the BTNX nasal device offers fast, easy-to-use, and reliable screening. Testing all staff 1-2 times/week help detect the virus early and decrease the likelihood of spreading COVID-19.
Negative test results do not exclude infection with COVID-19 (so face masks, social distancing and good hygiene practice must be maintained)
Positive test results or symptomatic persons require immediate confirmatory testing using a polymerase chain reaction (PCR) test.
Must be used by relevant practitioners, or persons under their supervision, who are trained in the correct use of the tests and interpretation of test results.
Documents
COV-19C25 BTNX Flyer
Australian Register of Therapeutic Goods Certificate - BTNX
Impact of the Omicron variant of SARS-CoV-2 on BTNX’s Rapid Response®
Rapid response diagnostics BTNX
Usability Nasal-Nasopharyngeal-Oropharyngeal Brochure
Pricing excludes GST.